Cooper recently announced that it is the first hospital in the country to use Viz Aortic, an innovative artificial intelligence-powered software designed to detect abdominal aortic aneurysms (AAA).
An abdominal aortic aneurysm is a bulging or ballooning in a portion of the aorta that runs through the abdomen. This bulge can break open, causing life-threatening internal bleeding if not caught in time. The cutting-edge Viz Aortic technology will help physicians identify patients with undiagnosed AAA, potentially saving lives.
“We are proud to be the first hospital in the U.S. to use Viz Aortic in our daily clinical practice,” said Philip M. Batista, MD, a vascular and endovascular surgeon at Cooper who led the clinical implementation of the new technology. “This technology will enable us to detect abdominal aortic aneurysms earlier, which can lead to improved surveillance, more thoughtful interventional planning, and ultimately lifesaving care.”
“Our partnership with Viz.ai aligns with our commitment to delivering exceptional patient care by utilizing groundbreaking advancements in technology. This software holds immense potential for transforming the way we approach patient care,” said Snehal Gandhi, MD, Chief Medical Information Officer and Medical Director of Hospital Medicine at Cooper.
Viz Aortic uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA) from any scanner in a hospital network. The new artificial intelligence (AI) algorithm and clinical workflow solution will be a part of the Viz™ AORTIC Module, an AI solution designed to accelerate treatment decisions for all aortic pathology. Viz Aortic is designed to analyze CT scans for signs of aneurysms in real time. The software uses advanced AI algorithms to identify subtle changes in the size and shape of the aorta, providing physicians with a powerful tool for early diagnosis and intervention.
“Our mission at Viz.ai is to increase patient access to lifesaving treatments,” said Jayme Strauss, Chief Clinical Officer at Viz.ai. “We’re thrilled to expand our partnership with Cooper University Health Care into these critical vascular diseases and look forward to improving patient outcomes together.”
With Viz Aortic, Cooper aims to improve the quality of care for patients with abdominal aortic aneurysms by enabling earlier detection and intervention. We will continue to evaluate the impact of the technology on patient outcomes and are committed to driving innovation in vascular care.